MDT

89.73

+0.54%↑

VEEV

282.11

+0.97%↑

A

113.48

+0.27%↑

WBA

11.52

+0.09%↑

HQY

97.58

+1.43%↑

MDT

89.73

+0.54%↑

VEEV

282.11

+0.97%↑

A

113.48

+0.27%↑

WBA

11.52

+0.09%↑

HQY

97.58

+1.43%↑

MDT

89.73

+0.54%↑

VEEV

282.11

+0.97%↑

A

113.48

+0.27%↑

WBA

11.52

+0.09%↑

HQY

97.58

+1.43%↑

MDT

89.73

+0.54%↑

VEEV

282.11

+0.97%↑

A

113.48

+0.27%↑

WBA

11.52

+0.09%↑

HQY

97.58

+1.43%↑

MDT

89.73

+0.54%↑

VEEV

282.11

+0.97%↑

A

113.48

+0.27%↑

WBA

11.52

+0.09%↑

HQY

97.58

+1.43%↑

Search

Day One Biopharmaceuticals Inc

Closed

SectorHealthcare

6.63 0.61

Overview

Share price change

24h

Current

Min

6.51

Max

6.73

Key metrics

By Trading Economics

Income

30M

-36M

Sales

1.6M

31M

Profit margin

-117.018

Employees

181

EBITDA

24M

-40M

Recommendations

By TipRanks

Recommendations

Strong Buy

12 Months Forecast

+309.13% upside

Dividends

By Dow Jones

Next Earnings

29 lip 2025

Market Stats

By TradingEconomics

Market Cap

-132M

672M

Previous open

6.02

Previous close

6.63

News Sentiment

By Acuity

50%

50%

154 / 376 Ranking in Healthcare

Technical Score

By Trading Central

Confidence

Very Strong Bearish Evidence

Day One Biopharmaceuticals Inc Chart

Wyniki osiągnięte w przeszłości nie są gwarantem przyszłych wyników.

Related News

15 lip 2025, 23:41 UTC

Market Talk

Nikkei May Trade in Range Amid Tariff Uncertainty -- Market Talk

15 lip 2025, 23:40 UTC

Market Talk

Gold Edges Higher on Possible Position Adjustments -- Market Talk

15 lip 2025, 23:05 UTC

Market Talk

Auckland International Airport Passenger Growth May Disappoint Again -- Market Talk

15 lip 2025, 21:36 UTC

Market Talk

Global Forex and Fixed Income Roundup: Market Talk

15 lip 2025, 21:36 UTC

Market Talk

Canada CPI Data Fuel Rate-Prediction Revisions -- Market Talk

15 lip 2025, 20:50 UTC

Market Talk

Tech, Media & Telecom Roundup: Market Talk

15 lip 2025, 20:50 UTC

Market Talk
Earnings

Financial Services Roundup: Market Talk

15 lip 2025, 20:50 UTC

Market Talk

Auto & Transport Roundup: Market Talk

15 lip 2025, 20:50 UTC

Market Talk

Health Care Roundup: Market Talk

15 lip 2025, 20:14 UTC

Acquisitions, Mergers, Takeovers

Chinese EV Makers to Combine. Geely Is Buying Zeekr. -- Barrons.com

15 lip 2025, 20:07 UTC

Earnings

BlackRock Shares Tumble After Big Client Redemption Blunts Quarterly Results -- Update

15 lip 2025, 20:06 UTC

Market Talk

Nvidia, AMD Seen Benefiting from Return to Chinese Chip Sales -- Market Talk

15 lip 2025, 19:54 UTC

Market Talk

Global Equities Roundup: Market Talk

15 lip 2025, 19:54 UTC

Market Talk

Meta CEO Hints at Higher Revenues, Expenses With Data Center Plans -- Market Talk

15 lip 2025, 19:38 UTC

Market Talk

Oil Falls As Eventual Oversupply Concerns Weigh -- Market Talk

15 lip 2025, 19:09 UTC

Market Talk

U.S. Natural Gas Futures Post Back-to-Back Gains -- Market Talk

15 lip 2025, 19:07 UTC

Market Talk

Canada CFOs Willing to Take Risks, Increase Spending -- Market Talk

15 lip 2025, 19:03 UTC

Market Talk

Gold Slips as Big Buyers Pull Back -- Market Talk

15 lip 2025, 18:32 UTC

Acquisitions, Mergers, Takeovers

Waters Corp. Deal for Becton Dickinson Unit a Long-Term Play With Some Risks -- Analysis

15 lip 2025, 18:31 UTC

Acquisitions, Mergers, Takeovers

Waters Deal for Becton Unit Pairs Near-Term Risks With Possible Long-Term Rewards, Analysts Say

15 lip 2025, 18:13 UTC

Market Talk

Canada Adopts 'Note of Realism' in US Trade Talks, Setting Stage for Possible Tariff Deal -- Market Talk

15 lip 2025, 17:40 UTC

Market Talk

Canadian Inflation Adds to Case for Bank of Canada Extending Pause -- Market Talk

15 lip 2025, 17:40 UTC

Market Talk

Global Forex and Fixed Income Roundup: Market Talk

15 lip 2025, 17:25 UTC

Acquisitions, Mergers, Takeovers

National Fuel Gas Gets Rare Double Upgrade. Buy the Stock, Analyst Says. -- Barrons.com

15 lip 2025, 17:24 UTC

Market Talk

Dollar Gains Strength After Inflation Data -- Market Talk

15 lip 2025, 16:49 UTC

Market Talk

Oil Futures Likely to Continue Sideways Trade -- Market Talk

15 lip 2025, 16:20 UTC

Market Talk
Earnings

Financial Services Roundup: Market Talk

15 lip 2025, 16:20 UTC

Market Talk

Auto & Transport Roundup: Market Talk

15 lip 2025, 16:20 UTC

Market Talk

Health Care Roundup: Market Talk

15 lip 2025, 15:42 UTC

Market Talk

Coca-Cola Seen as Top Pick Ahead of Consumer Staples Earnings -- Market Talk

Peer Comparison

Price change

Day One Biopharmaceuticals Inc Forecast

Price Target

By TipRanks

309.13% upside

12 Months Forecast

Average 26.88 USD  309.13%

High 36 USD

Low 18 USD

Based on 9 Wall Street analysts offering 12 month price targets forDay One Biopharmaceuticals Inc - Dist in the last 3 months.

Rating Consensus

By TipRanks

Strong Buy

9 ratings

8

Buy

1

Hold

0

Sell

Technical Score

By Trading Central

6.26 / 7.47Support & Resistance

Short Term

Very Strong Bearish Evidence

Intermediate Term

Bullish Evidence

Long Term

Bearish Evidence

Sentiment

By Acuity

154 / 376 Ranking in Healthcare

News Sentiment

Neutral

Volatility

Below average

News Volume (RCV)

Average

Financials

Selling and administration expenses

Operating expenses

Pre-tax profit

Sales

Cost of sales

Gross profit on sales

Interest expense on debt

EBITDA

Operating profit

$

About Day One Biopharmaceuticals Inc

Day One Biopharmaceuticals, Inc., a clinical-stage biopharmaceutical company, develops and commercializes targeted therapies for patients with genomically defined cancers. Its lead product candidate is tovorafenib, an oral brain-penetrant type II pan-rapidly accelerated fibrosarcoma kinase inhibitor that is in Phase II clinical trial for pediatric patients with relapsed/ refractory low-grade glioma. The company is also developing Pimasertib, an oral small molecule inhibitor of mitogen-activated protein kinase kinases 1 and 2. Day One Biopharmaceuticals, Inc. was incorporated in 2018 and is headquartered in Brisbane, California.